causal

Sequencing cost collapsed, but delivery is the bottleneck

Identifying a patient's mutation is now cheap, with a genome sequenced for a couple hundred dollars versus over a billion for the Human Genome Project, so the limiting factor for gene therapy is delivery to the right cell types, and every organ poses a unique delivery challenge.

causalpending

Speaker

Jeff Coller

Evidence Quote

“We can sequence a person's genome for a matter of a couple of hundred bucks now. The Human Genome Project cost over a billion dollars... But delivery is gonna be the challenge.”

Source

357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics— Sean Carroll's Mindscape
Created: 11/17/2026, 7:10:08 AM

Your notes

Loading notes...